REVLIMID lenalidomide is a prescription medicine used to treat adults with multiple myeloma MM in combination with the medicine dexamethasone or as maintenance treatment after autologous hematopoietic stem cell transplantation a type of stem cell transplant that uses your own stem cells. The exact mechanism through which lenalidomide stops the growth of.
Revlimid must not be given to a pregnant woman or a woman who intends to become pregnant.
What is revlimid medication. Revlimid lenalidomide is a member of the miscellaneous antineoplastics drug class and is commonly used for Anemia Follicular Lymphoma Lymphoma and others. Lenalidomide is similar to thalidomide Thalomid an older cancer medicine that although effective was associated with serious side effects. Revlimid is contraindicated in patients who have demonstrated severe hypersensitivity eg angioedema Stevens-Johnson syndrome toxic epidermal necrolysis to lenalidomide see Warnings and Precautions 59 515.
It is used in the newly diagnosed maintenance therapy and relapsed andor refractory settings. Before you begin taking REVLIMID. Lenalidomide is similar to a drug called thalidomide so Revlimid is called a thalidomide analogue.
It is used to treat multiple myeloma certain types of lymphoma and some myelodysplastic syndromes that cause severe anemia requiring. It works by slowing or stopping the growth of cancercells. LENALIDOMIDE is a chemotherapy drug that targets specific proteins within cancer cells and stops the cancer cell from growing.
Lenalidomide Revlimid is an oral anti- cancer medication. It is also used to treat anemiain patients with certain bloodbone marrowdisorders. MEDICATION GUIDE REVLIMID rev-li-mid lenalidomide capsules.
Revlimid is a prescription chemotherapy medication that contains the active ingredient Lenalidomide. REVLIMID is similar to the medicine thalidomide which is known to cause severe life-threatening birth defects. REVLIMID has harmed unborn animals in animal testing.
Revlimid can be taken by. Warnings and Precautions Embryo-Fetal Toxicity. Revlimid is a thalidomide analogue and is contraindicated for use during pregnancy.
Females must not get pregnant. REVLIMID should not be used to treat people who have chronic lymphocytic leukemia CLL unless. Prescribed As Part Of Chemotherapy Treatment Revlimid is used to treat myelodysplastic syndrome MDS multiple myeloma and mantle cell lymphoma.
Prescribed for Multiple Myeloma Myelodysplastic Diseases Follicular Lymphoma Lymphoma Mantle Cell Lymphoma Anemia. Revlimid may also be used for purposes not listed in this medication guide. Pregnancy category X Revlimid may cause fetal harm when given to a pregnant woman.
Revlimid also known as lenalidomide is an oral cancer drug that is used for the treatment of multiple myeloma. REVLIMID has not been tested in pregnant females. REVLIMID should not be used to treat people who have chronic lymphocytic leukemia CLL unless.
Lenalidomideis used to treat various types of cancers. How Does It Work. It is part of a class of drugs called immunomodulatory drugs IMiDs which work against cancer cells partly by supporting the function of the.
Dexamethasone reduces inflammation and calms down an overactive immune system and is significantly more potent than prednisolone. What is the most important information I should know about REVLIMID. Revlimid is a brand-name medication that contains the drug lenalidomide.
REVLIMID lenalidomide is a prescription medicine used to treat adults with multiple myeloma MM in combination with the medicine dexamethasone or as maintenance treatment after autologous hematopoietic stem cell transplantation a type of stem cell transplant that uses your own stem cells. It is typically taken orally once daily for 21 days of a 28-day cycle at which point the need for the drug is reassessed based on cancer progression or improvement. Revlimid lenalidomide an immunomodulatory drug IMiD is the first oral medication that was developed for treatment of multiple myeloma.
Revlimid is similar to the medication thalidomide a medication known to cause severe life-threatening birth defects.